EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

Author(s):
Driel, P.B.A.A. van; Boonstra, M.C.; Slooter, M.D.; Heukers, R.; Stammes, M.A.; Snoeks, T.J.A.; Bruijn, H.S. de; Diest, P.J. van; Vahrmeijer, A.L.; Henegouwen, P.M.P.V.E.; Velde, C.J.H. van de (0000-0003-0104-1800); Lowik, C.G.M.; Robinson, D.J.; Oliveira, S.
Published
2016
Publication type
Article / Letter to editor
Photodynamic therapyTumor targetingNanobody or VHHQuantitative fluorescence spectroscopyEGFRHead and neck cancer
Date issued
2016-05-10
Language
English
Is part of
Journal of Controlled Release (2016), Vol. 229, p. 93-105
hdl
1887/111773
doi
10.1016/j.jconrel.2016.03.014